The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals Ltd

BSE 500420 · NSE TORNTPHARM · ISIN INE685A01028 · Group A · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹5,025.00

+2.80%

BSE close, 28 August 2026

Market cap

₹191,128.01 cr

38.0 cr shares · Large cap

Free float

₹58,742.05 cr

as published

P/E · P/B

89.6× · 25.40×

EPS ₹56.08 · BV ₹197.83

FY25-26 rev / PAT

10,712.00 / 2,192.00

₹ cr, as filed

Filings, window

21

6 selected · 29%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹3,480.00 52-WK HIGH ₹5,249.95 ₹5,025.00 87% of range
Against 52-week high-4.3%
Against 52-week low+44.4%
Day change+2.80%
Size bandLarge cap
Index membershipNIFTY 500

Valuation as published by BSE

Earnings per share₹56.08
Price / earnings89.60×
Price / book25.40×
Book value — derived, price ÷ P/B₹197.83
Return on equity28.34%
Operating margin36.82%
Net margin11.83%

Consistency check

P/B ÷ P/E, which must equal ROE
28.35%
ROE as published
28.34%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 4,158.00 492.00 12.94 36.82% 11.83%
Mar-26 · Q 2,735.00 467.00 13.80 37.07% 17.07%
FY25-26 10,712.00 2,192.00 64.75 37.36% 20.46%

Quarter on quarter

Revenue, quarter on quarter
+52.0%
Net profit, quarter on quarter
+5.4%
Operating margin, quarter on quarter
-25 bps

Disclosure profile 21 filings in the window

0 median 17.0 p75 · 25 sector max 52 21 64th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Change in Management2
Acquisition1
Board Outcome1
Credit Rating1
Results1
Selected sub-total6
Procedural
Analyst / Investor Meet5
General3
Postal Ballot3
Newspaper Publication2
Board Meeting1
Trading Window1
Procedural sub-total15
Total21

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group A, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

21 filings · 6 selected · busiest 2026-07-30

Filing rhythm · the twelve most recent

2026-08-062026-10-09

SelectedProcedural

Filings

21 in the window · 15 earlier on record

  1. 9 October 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Post Quarterly Financial Result Conference call with investors / analyst

    Company Update / Analyst / Investor Meet View filing →

  2. 7 October 2026 ·

    Credit Rating

    Credit Rating

    Intimation of Credit Rating

    Company Update / Credit Rating View filing →

  3. 6 October 2026 ·

    Board Meeting

    Board Meeting Intimation for To Consider And Approve The Audited Financial Results On Standalone Basis And Unaudited Financial Results (With Limited Review) On Consolidated Basis Of The Company For The Quarter And Half Year Ended On 30-Sep-26.

    Torrent Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2026 ,inter alia, to consider and approve the Audited Financial ....

    Board Meeting / Board Meeting View filing →

  4. 28 September 2026 ·

    Acquisition

    Updates on Acquisition

    Disclosure pursuant to Regulation 30 read with Schedule III of SEBI Listing Regulations

    Company Update / Acquisition View filing →

  5. 28 September 2026 ·

    Trading Window

    Closure of Trading Window

    Intimation of Closure of Trading Window Period - Q2

    Insider Trading / SAST / Closure of Trading Window View filing →

  6. 10 September 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of Schedule of Investor Meets

    Company Update / Analyst / Investor Meet View filing →

  7. 9 September 2026 ·

    Newspaper Publication

    Newspaper Publication

    Newspaper advertisement in respect of special window for transfer and dematerialisation of physical shares

    Company Update / Newspaper Publication View filing →

  8. 7 September 2026 ·

    Postal Ballot

    Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

    Outcome of Postal Ballot

    AGM/EGM / Postal Ballot View filing →

  9. 7 September 2026 ·

    Postal Ballot

    Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

    Scrutinizer's Report on the Postal Ballot

    AGM/EGM / Postal Ballot View filing →

  10. 11 August 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

    Company Update / Analyst / Investor Meet View filing →

  11. 11 August 2026 ·

    General

    Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - ESG Rating

    ESG Rating

    Company Update / General View filing →

  12. 6 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    Newspaper Advertisement for completion of dispatch of Postal Ballot Notice

    Company Update / Newspaper Publication View filing →

  13. 5 August 2026 ·

    Postal Ballot

    Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

    Notice of Postal Ballot

    AGM/EGM / Postal Ballot View filing →

  14. 4 August 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Outcome

    Transcript of Conference call with Analysts / Investors on Financial Results for the quarter ended 30th June, 2026

    Company Update / Analyst / Investor Meet View filing →

  15. 30 July 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Outcome

    Recording Link of Analyst call - Q1 Results

    Company Update / Analyst / Investor Meet View filing →

  16. 30 July 2026 ·

    Change in Management

    Change in Management

    Change in Senior Management Personnel

    Company Update / Change in Management View filing →

  17. 30 July 2026 ·

    Board Outcome

    Board Meeting Outcome for Outcome Of Board Meeting Dated 30-Jul-26

    Outcome of Board Meeting dated 30-Jul-26

    Board Meeting / Outcome of Board Meeting View filing →

  18. 30 July 2026 ·

    Results

    Results For Quarter Ended 30-Jun-26

    Results for quarter ended 30-Jun-26

    Result / Financial Results View filing →

  19. 28 July 2026 ·

    Change in Management

    Change in Management

    Appointment of Shanti Ekambaram as an Independent Director of the Company

    Company Update / Change in Management View filing →

  20. 27 July 2026 ·

    General

    Receipt Of Final Listing And Trading Approval For Equity Shares Of The Company Issued And Allotted In Terms Of Scheme Of Amalgamation

    Receipt of final listing and Trading approval for Equity shares of the Company issued and allotted in terms of Scheme of Amalgamation

    Company Update / General View filing →

  21. 20 July 2026 ·

    General

    Allotment Of 4,19,22,416 Fully Paid-Up Equity Shares Of The Company To The Eligible Shareholders Of J. B. Chemicals & Pharmaceuticals Limited As On The Record Date I.E. 17Th July, 2026, In Terms Scheme Of Amalgamation Of J. B. Chemicals & Pharmaceuticals Limited With Torrent Pharmaceuticals Limited And Their Respective Shareholders

    Allotment of Equity shares of the Company to eligible shareholders of J B Chemicals as on Record Date in terms of Scheme of Amalgamation

    Company Update / General View filing →

RSS feed for Torrent Pharmaceuticals Ltd · the 50 most recent filings